Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JACC: Advances, adding:
“How do we predict recurrence post Left Ventricular Thrombus ( LVT ) resoultion?
Echo at the time of LVT resolution preditctive than the time of Diagnosis
After LVT resolution, patient with left ventricular aneurysm (LVA) remained at high risk of recurrence regardless of anticoagulation status, with recurrence rates approaching 50–70% (Figure 1).
Stopping oral anticoagulation (OAC) after LVT resolution increased recurrence risk even in patients without LVA, rising to 19%(Figure 2).
Risk stratification combining LVA status and OAC use revealed a clear gradient of recurrence risk (Figure 3):
Without LVA and receiving OAC: 5/113 (4%)
Without LVA and not receiving OAC: 22/116 (19%)
With LVA and receiving OAC: 4/13 (31%)
With LVA and not receiving OAC: 5/10 (50%)
Highest recurrence: Patients with LVA who were not receiving OAC
Lowest recurrence: Patients without LVA who were receiving OAC
The key question:
If recurrence risk remains elevated across all groups, who can truly stop OAC after LVT resolution?
Stay tunned for Mayo LVT part 3″
Title: Clinical and Echocardiographic Factors Associated With Left Ventricular Thrombus Recurrence
Authors: Kirsten M. Lipps, Hossam Elbenawi, Samuel Heller Jr., Robert D. McBane, Waldemar E. Wysokinski, Ana I. Casanegra, Stanislav Henkin, Thom W. Rooke, Paul W. Wennberg, David A. Liedl, Raymond C. Shields, Damon E. Houghton
Other posts featuring Hossam El Benawi on Hemostasis Today.
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026
-
Jun 23, 2026, 16:48Khusboo Kumari: Laboratory Skills in Hematology
-
Jun 23, 2026, 16:45Advancing Sickle Cell Disease Research Through Community Support – ASH